MedicoX Partner Oramed Holds Oral Insulin Technology Briefing Session

[Asia Economy Reporter Jang Hyowon] Nasdaq-listed Oramed Pharmaceuticals (hereinafter Oramed) announced on the 30th that it will hold the "World's First Oral Insulin Technology Briefing" together with KOSDAQ-listed Medicox at the Chosun Palace Hotel on December 29.

This event was organized to introduce and expand the reach of Oramed's oral insulin, which is being developed as the world's first. Oramed executives including CEO Nadav Kidron, CSO Miriam Kidron, and CCO Michael Rabinowitz will attend. The event plans to invite diabetes patients, medical professionals, individual investors, and media outlets.

At the technology briefing, Oramed will introduce the oral insulin technology and explain the FDA Phase 2 results and ongoing FDA Phase 3 progress of the oral insulin candidate 'ORMD-0801'. To aid understanding of the technology, a Q&A session will be held for attendees including diabetes patients. Afterwards, a panel discussion featuring renowned endocrinologists and academic experts will be conducted on the differences between oral insulin and injectable insulin.

Unlike injectable drugs, oral insulin acts similarly to endogenous insulin produced by the body. It is regarded as a groundbreaking new drug that can overcome the drawbacks of injections such as pain, risk of complications, and inconvenience.

Oramed, a pharmaceutical company developing drug delivery platforms, signed an exclusive domestic distribution agreement with Medicox on the 14th under the oral insulin license. Through this, Medicox will distribute oral insulin in Korea for 10 years after obtaining approval from the Korea Food and Drug Administration for 'ORMD-0801'.

Oramed CEO Nadav Kidron stated, "As oral insulin is expected to be a game changer in the diabetes treatment market, we are honored to introduce the world's first oral insulin through this event," and added, "Through our partnership with Medicox, we will do our best to ensure the product is distributed safely and quickly within Korea after its launch."